Fmoc-Lys(Mmt)-OH is a protected lysine derivative used in solid-phase peptide synthesis. Its Fmoc group enables temporary protection of the alpha-amino group during peptide assembly, while the Mmt group protects the lysine side chain.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 159857-60-0
Fmoc-D-Lys-OH.HCl
Fmoc-protected amino acid intermediate
N-Fmoc-7-methyl-L-tryptophan
Fmoc-protected amino acid intermediate
(3R)-1-{[(9H-FLUOREN-9-YL)METHOXY]CARBONYL}PIPERIDINE-3-CARBOXYLIC ACID
Fmoc-protected amino acid intermediate
Fmoc-4-amino-tetrahydropyran-4-carboxylic acid
Fmoc-protected amino acid intermediate
(2S)-5-((aminocarbonyl)amino)-2-(((2S)-2-amino-3-methylbutanoyl)amino)-N-(4-(hydroxymethyl)phenyl)pentanamide
antibody-drug conjugate linker intermediate
MC-Val-Cit-PAB-OH
Pharmaceutical intermediate for antibody-drug conjugates
(S)-2-((S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-METHYLBUTANAMIDO)-5-UREIDOPENTANOIC ACID
peptide synthesis intermediate
Dxd
exatecan derivative for antibody-drug conjugate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[(4-methoxyphenyl)-diphenylmethyl]amino]hexanoic acid
CTYHQVFFQRDJSN-LHEWISCISA-N
COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)NCCCC[C@@H](C(=O)O)NC(=O)OCC4C5=CC=CC=C5C6=CC=CC=C46